On October 31, 2022, Nurosene Health Inc closed the transaction. The company now issued 2,99,000 units at a price of CAD 0.25 per unit for aggregate gross proceeds of CAD 74,750 in its second tranche for total gross proceeds of $802,250. In connection with the closing of the private placement, the company paid finder's fee commissions in the aggregate amount of CAD 5,232.50 and issued 20,930 broker warrants.

As a result of closing the private placement, there are 45,730,102 common shares of issued and outstanding.